Tag Archives: Covance

DIA: Does Six Sigma Stifle R&D Innovation?

Can the management style known as Six Sigma help improve the probability of a drug’s commercial success, or do its black-belted acolytes punch holes in the creative process needed for innovative R&D discovery?
Posted in IP, leadership, R&D, Strategy | Also tagged , , | 4 Comments

M&A Round-up • 3/25/2009

The latest round of merger and acquisition activities courtesy of our friends at Pharm Exec Europe: • Just days after its purchase of Genentech, Roche has made another acquisition, albeit a much smaller one, of the German firm Innovatis. Roche will pay EUR 15 million for the cell analytics company. • Oxford Gene Technology (OGT) […]
Posted in Deals | Also tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta